1093582

AJENAT PHARMACEUTICALS LLC — FEI 3033007964

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 24, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Largo, FL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)